Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 6.653M
March 31, 2026 7.258M
December 31, 2025 8.337M
September 30, 2025 6.648M
June 30, 2025 6.476M
March 31, 2025 4.594M
December 31, 2024 2.40M
September 30, 2024 2.197M
June 30, 2024 0.917M
March 31, 2024 1.611M
December 31, 2023 2.506M
September 30, 2023 2.326M
June 30, 2023 2.55M
March 31, 2023 2.335M
Date Value
December 31, 2022 1.942M
September 30, 2022 1.517M
June 30, 2022 1.114M
March 31, 2022 0.594M
December 31, 2021 -0.195M
September 30, 2021 0.109M
June 30, 2021 -0.37M
March 31, 2021 -0.558M
December 31, 2020 -0.238M
September 30, 2020 -0.25M
June 30, 2020 -0.25M
March 31, 2020 -0.25M
December 31, 2019 -0.15M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Champions Oncology, Inc. 28.93M
Medpace Holdings, Inc. 772.42M
Avantor, Inc. 2.012B
Personalis, Inc. 8.838M
Adaptive Biotechnologies Corp. 224.00M